Mirum Pharmaceuticals Inc
NASDAQ:MIRM

Watchlist Manager
Mirum Pharmaceuticals Inc Logo
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Watchlist
Price: 64.04 USD -2.08%
Market Cap: 3.3B USD

Wall Street
Price Targets

MIRM Price Targets Summary
Mirum Pharmaceuticals Inc

Wall Street analysts forecast MIRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MIRM is 89.76 USD with a low forecast of 80.8 USD and a high forecast of 99.75 USD.

Lowest
Price Target
80.8 USD
26% Upside
Average
Price Target
89.76 USD
40% Upside
Highest
Price Target
99.75 USD
56% Upside
Mirum Pharmaceuticals Inc Competitors:
Price Targets
2616
CStone Pharmaceuticals
134% Upside
STOK
Stoke Therapeutics Inc
4% Downside
300601
Shenzhen Kangtai Biological Products Co Ltd
29% Upside
397030
AprilBio Co Ltd
16% Upside
GNS
Genus PLC
14% Upside
RPTX
Repare Therapeutics Inc
42% Upside
RNA
Avidity Biosciences Inc
4% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
8% Upside

Revenue
Forecast

Revenue Estimate
Mirum Pharmaceuticals Inc

The compound annual growth rate of Mirum Pharmaceuticals Inc's revenue for the next 3 years is 30%.

N/A
Past Growth
30%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mirum Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Mirum Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MIRM's stock price target?
Price Target
89.76 USD

According to Wall Street analysts, the average 1-year price target for MIRM is 89.76 USD with a low forecast of 80.8 USD and a high forecast of 99.75 USD.

What is Mirum Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
30%

The compound annual growth rate of Mirum Pharmaceuticals Inc's revenue for the next 3 years is 30%.

Back to Top